0001628280-21-012225.txt : 20210615
0001628280-21-012225.hdr.sgml : 20210615
20210615100643
ACCESSION NUMBER: 0001628280-21-012225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210610
FILED AS OF DATE: 20210615
DATE AS OF CHANGE: 20210615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JACOB GARY S
CENTRAL INDEX KEY: 0001266802
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35558
FILM NUMBER: 211017132
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiff Oncology, Inc.
CENTRAL INDEX KEY: 0001213037
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 272004382
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-952-7570
MAIL ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Trovagene, Inc.
DATE OF NAME CHANGE: 20130304
FORMER COMPANY:
FORMER CONFORMED NAME: TrovaGene Inc.
DATE OF NAME CHANGE: 20110830
FORMER COMPANY:
FORMER CONFORMED NAME: XENOMICS INC
DATE OF NAME CHANGE: 20040719
4
1
wf-form4_162376598346799.xml
FORM 4
X0306
4
2021-06-10
0
0001213037
Cardiff Oncology, Inc.
CRDF
0001266802
JACOB GARY S
C/O CARDIFF ONCOLOGY, INC.
11055 FLINTKOTE AVENUE
SAN DIEGO
CA
92121
0
0
0
1
Former Director
Stock Options
2.6
2021-06-10
4
J
0
28858
0
A
2021-06-10
2023-06-10
Common Stock
28858.0
76106
D
Stock Options
447.84
2021-06-10
4
J
0
293
0
A
2023-06-10
Common Stock
293.0
76106
D
Stock Options
316.08
2021-06-10
4
J
0
218
0
A
2014-12-11
2023-06-10
Common Stock
218.0
76106
D
Stock Options
516.96
2021-06-10
4
J
0
223
0
A
2016-03-17
2023-06-10
Common Stock
223.0
76106
D
Stock Options
372.96
2021-06-10
4
J
0
223
0
A
2017-01-04
2023-06-10
Common Stock
223.0
76106
D
Stock Options
51.84
2021-06-10
4
J
0
530
0
A
2018-10-04
2023-06-10
Common Stock
530.0
76106
D
Stock Options
21.6
2021-06-10
4
J
0
755
0
A
2019-01-23
2023-06-10
Common Stock
755.0
76106
D
Stock Options
2.48
2021-06-10
4
J
0
44734
0
A
2020-06-20
2023-06-10
Common Stock
44734.0
76106
D
In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 28,858 stock options to June 10, 2021 from June 17, 2021. In addition, the Compensation Committee extended the expiration date of the stock options to June 10, 2023.
Expiration date of the stock options was extended to June 10, 2023.
8,805 of the stock options vest immediately. 4,077 of the stock options vest on each of 2/25/2015 and 2016 and 4,076 of the stock options vest on 2/25/2017.
/s/ Gary Jacob
2021-06-15